Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out

Comments
Loading...

Researchers at the University of Texas (UT) Dell Medical School in Austin will use brain scans to examine responses following treatment with psilocybin and 5-MeO-DMT for combatants suffering from post-traumatic stress disorder (PTSD), traumatic brain injuries and other related conditions.

The Mission Within is one of the numerous non-profit organizations providing access to psychedelic therapy for veterans at retreats located outside the U.S. for reasons corresponding to these substances’ legal status inside the country.

The NGO’s founder Dr. Martin Polanco explained that the current need for further evidence in order to get these kinds of therapies approved has triggered the organization’s participation in the university’s study. “We believe it is important to document scientifically what we have been seeing anecdotally," Polanco explained.

The 2021-created Center for Psychedelic Research and Therapy at UT is conducted by Drs. Greg Fonzo and Charles Nemeroff, with a focus on evaluating which populations would most benefit from psychedelic-assisted therapy, how often it should be administered and at what doses.

The center’s first study will assess the prolonged grief diagnosis, which Dr. Fonzo describes as a “black hole of misery.”

The study is now recruiting Gold Star wives with the aim of studying thirty participants. Half of them will be given psilocybin, five will take 5-MeO-DMT and the remaining 10 will be given a placebo.

The Mission Within will administer the compounds outside the U.S., and participants will be brought to Austin for functional magnetic resonance imaging (fMRI,) scans to measure real-time brain responses- before and after drug ingestion.

"We're going to be investigating what are called behavioral tasks that people will complete inside the fMRI scanner, some of which are very unique to grief,” Dr. Fonzo explained, including seeing pictures of their deceased spouses or looking at specific grief-related words.

Blood work will also be analyzed, in order to see how genetics influences each participant’s response to the psychedelic therapy.

Photo by Natalie Grainger on Unsplash

Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!